Tsukamoto Yoshihiro 塚本佳広

Researcher Number	90648891
Other IDs
Affiliation (Current)	2025: 新潟大学, 医歯学総合病院, 助教
Affiliation (based on the past Project Information) *help	2019 – 2023: 新潟大学, 医歯学総合病院, 助教 2018: 新潟大学, 脳研究所, 特任助教 2017: 新潟大学, 脳研究所, 非常勤講師
Review Section/Research Field	Principal Investigator Basic Section 56010:Neurosurgery-related / Tumor therapeutics
Keywords	Principal Investigator glioblastoma / Glioblastoma / PARP / GBM / Drug screening / operation / SLFN11 / Glioma stem cell / CED / TMZ耐性 … More / 膠芽腫 / temozolomide / EUrd / glioma Less

化学療法感受性規定因子SLFN11制御による膠芽腫新規治療法の開発Principal Investigator
- Principal Investigator
  
  塚本佳広
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Niigata University
New therapy for recurrent glioblastoma, EUrd-CEDPrincipal Investigator
- Principal Investigator
  
  Tsukamoto Yoshihiro
- Project Period (FY)
  2017 – 2021
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Niigata University

All 2022 2019 2018

All Journal Article

[Journal Article] Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin2022
- Author(s)
  Nakata Satoshi、Murai Junko、Okada Masayasu,,,,,Tateishi Kensuke、Yamashita Shinji、Eberhart Charles G、Natsumeda Manabu
- Journal Title
  
  Neuro-Oncology
  
  Volume: 25 Issue: 5 Pages: 899-912
- DOI
  10.1093/neuonc/noac243
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K09210, KAKENHI-PROJECT-22K16679, KAKENHI-PROJECT-21KK0156, KAKENHI-PROJECT-20K15919, KAKENHI-PROJECT-23K24297, KAKENHI-PROJECT-22K20953, KAKENHI-PROJECT-21H03042
[Journal Article] Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy2019
- Author(s)
  Kanemaru Yu、Natsumeda Manabu、Okada Masayasu、Saito Rie、Kobayashi Daiki、Eda Takeyoshi、Watanabe Jun、Saito Shoji、Tsukamoto Yoshihiro、Oishi Makoto、Saito Hirotake、Nagahashi Masayuki、Sasaki Takahiro、Hashizume Rintaro、Aoyama Hidefumi、Wakai Toshifumi、Kakita Akiyoshi、Fujii Yukihiko
- Journal Title
  
  Acta Neuropathologica Communications
  
  Volume: 7 Issue: 1 Pages: 119-119
- DOI
  10.1186/s40478-019-0774-7
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K10888, KAKENHI-PROJECT-19K09476, KAKENHI-PROJECT-17K17735, KAKENHI-PROJECT-19K17262, KAKENHI-PROJECT-19K18418, KAKENHI-PROJECT-17K17739, KAKENHI-PROJECT-16H06276
[Journal Article] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas2019
- Author(s)
  Hideaki Abe, Manabu Natsumeda1, Masayasu Okada, Jun Watanabe, Yoshihiro Tsukamoto, Yu Kanemaru, Junichi Yoshimura, Makoto Oishi, Rintaro Hashizume, Akiyoshi Kakita and Yukihiko Fujii
- Journal Title
  
  Frontiers in Oncology
  
  Volume: 9 Pages: 1-10
- DOI
  10.3389/fonc.2019.01568
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18418, KAKENHI-PROJECT-17K17739, KAKENHI-PROJECT-17K10888, KAKENHI-PROJECT-19K09476, KAKENHI-PROJECT-17K17735
[Journal Article] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas2018
- Author(s)
  Hideaki Abe, Manabu Natsumeda, Yu Kanemaru, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Junichi Yoshimura, Makoto Oishi, Yukihiko Fujii
- Journal Title
  
  Neurol. Med. Chir.(Tokyo)
  
  Volume: 58 Issue: 7 Pages: 290-295
- DOI
  10.2176/nmc.ra.2018-0044
- NAID
  130007405002
- ISSN
  0470-8105, 1349-8029
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16631, KAKENHI-PROJECT-15K10355, KAKENHI-PROJECT-17K10888, KAKENHI-PROJECT-17K17735, KAKENHI-PROJECT-16H06276

1. FUJII Yukihiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. OISHI Makoto

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. TATEISHI Kensuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 柿田明美

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 渡邉潤

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tsukamoto Yoshihiro 塚本佳広

Research Projects

Research Products

Co-Researchers

化学療法感受性規定因子SLFN11制御による膠芽腫新規治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

New therapy for recurrent glioblastoma, EUrd-CEDPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas2018

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

Tsukamoto Yoshihiro 塚本 佳広

Research Projects

Research Products

Co-Researchers

化学療法感受性規定因子SLFN11制御による膠芽腫新規治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

New therapy for recurrent glioblastoma, EUrd-CEDPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas2018

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

Tsukamoto Yoshihiro 塚本佳広